Pedro M. Quintana Diez

Pedro M. Quintana Diez currently serves as the Executive Director of Research and Development and Clinical Lead at Organon since October 2021, and simultaneously holds positions as Chair of the Scientific Advisory Board and Chief Medical Officer at Elastrin Therapeutics Inc. With over 20 years of experience in Research and Development, Pedro has managed more than 120 clinical trials across various therapeutic areas, including Pain/Inflammation, Cardio/Vascular/Metabolic, Respiratory, Oncology, and Rare Diseases. Previous roles include Senior International Clinical Lead at Grünenthal Group and Global Senior Project Leader for AbbVie. Pedro's education includes a Doctor in Medicine degree from Universidad Nacional Autónoma de México and a residency in Internal Medicine at IMSS.